BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38642508)

  • 41. Mixed connective tissue disease.
    Venables PJ
    Lupus; 2006; 15(3):132-7. PubMed ID: 16634365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
    Whittingham S; Mackay IR; Tait BD
    Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. More evidence of distinctive features of mixed connective tissue disease.
    Hämeenkorpi R; Ruuska P; Forsberg S; Tiilikainen R; Mäkitalo R; Hakala M
    Scand J Rheumatol; 1993; 22(2):63-8. PubMed ID: 8480140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 45. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Basophils and IgE contribute to mixed connective tissue disease development.
    Lamri Y; Vibhushan S; Pacreau E; Boedec E; Saidoune F; Mailleux A; Crestani B; Blank U; Benhamou M; Papo T; Daugas E; Sacré K; Charles N
    J Allergy Clin Immunol; 2021 Apr; 147(4):1478-1489.e11. PubMed ID: 33338538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
    Munteanu A; Kundnani NR; Caraba A
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1314-1326. PubMed ID: 38436165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype.
    El Kamouni H; S Jalaledin D; Albert A; Hoa S; Vo C; Bourré-Tessier J; Rich É; Goulet JR; Koenig M; Pérez G; Choi MY; Troyanov Y; Satoh M; Fritzler MJ; Senécal JL; Landon-Cardinal O
    RMD Open; 2023 Oct; 9(4):. PubMed ID: 37797966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
    Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
    Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
    Bernardino V; Rodrigues A; Lladó A; Panarra A
    Rheumatol Int; 2020 Feb; 40(2):295-301. PubMed ID: 31451935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scleroderma overlap syndromes.
    Jablonska S; Blaszczyk M
    Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
    Todoroki Y; Satoh M; Kubo S; Kosaka S; Fukuyo S; Nakatsuka K; Saito K; Tanaka S; Nakayamada S; Tanaka Y
    Rheumatology (Oxford); 2024 Apr; 63(4):1068-1075. PubMed ID: 37421400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 'Autoantibody dominance' pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies.
    George J; Gilburd B; Levy Y; Afec A; Damianovich M; Ghirardello A; Doria A; Todesco S; Shoenfeld Y
    Pathobiology; 1997; 65(4):204-9. PubMed ID: 9396044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
    Szodoray P; Hajas A; Kardos L; Dezso B; Soos G; Zold E; Vegh J; Csipo I; Nakken B; Zeher M; Szegedi G; Bodolay E
    Lupus; 2012 Nov; 21(13):1412-22. PubMed ID: 22864236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
    Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
    Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease.
    Sato T; Fujii T; Yokoyama T; Fujita Y; Imura Y; Yukawa N; Kawabata D; Nojima T; Ohmura K; Usui T; Mimori T
    Arthritis Rheum; 2010 Dec; 62(12):3730-40. PubMed ID: 20722023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-U1RNP antibodies in patients with localized scieroderma.
    Yamane K; Ihn H; Kubo M; Kuwana M; Asano Y; Yazawa N; Tamaki K
    Arch Dermatol Res; 2001 Sep; 293(9):455-9. PubMed ID: 11758788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
    Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
    Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.